Q4 2024 Quipt Home Medical Corp Earnings Call Transcript
Key Points
- Quipt Home Medical Corp (QIPT) achieved record revenue of $245.9 million for fiscal 2024, representing a 16% year-over-year growth.
- The company reported a consistent adjusted EBITDA margin of 23.5%, leading to an adjusted EBITDA of $57.9 million, a 14% increase over the previous year.
- Quipt Home Medical Corp (QIPT) has expanded to over 135 locations across 26 states, serving over 314,000 active patients, enhancing its nationwide reach.
- The company's respiratory care focus, which represents approximately 80% of its product mix, aligns with macro trends such as the aging population and increased prevalence of COPD.
- Quipt Home Medical Corp (QIPT) maintains a conservative balance sheet with a net leverage ratio of 1.6x, providing flexibility for strategic initiatives and acquisitions.
- The company faced industry-wide challenges in fiscal 2024, impacting its financial performance and preventing it from achieving its target of 8% to 10% annualized organic growth.
- Adjusted EBITDA for fiscal Q4 2024 decreased by 8.8% year-over-year, with a margin of 21.8% compared to 24.6% in the previous year.
- Operating expenses as a percentage of revenue increased to 49.8% in fiscal year 2024 from 48.7% in the previous year, partly due to professional fees related to ongoing investigations.
- The ongoing civil investigative demand (CID) remains unresolved, creating uncertainty and potential financial implications for the company.
- The company's diabetes business, while growing, has lower margins compared to its respiratory products, potentially impacting overall profitability.
Thank you for standing by. This is the conference operator. Welcome to the fiscal fourth-quarter and audited full year 2024 earnings results conference call for Quipt Home Medical Corp. As a reminder, all participants are in listen-only mode, and the conference is being recorded. (Operator Instructions)
We remind you that the remarks today will include forward-looking statements that are subject to important risks and uncertainties. For more information on these risks and uncertainties, please see the reader advisory at the bottom of the company's results news release. The company's actual performance could differ materially from these statements.
At this point, I'd like to turn the call over to Chairman and Chief Executive Officer, Greg Crawford.
Thank you operator, and thank you to everyone joining us today. I'm Greg Crawford, Chairman and CEO of Quipt Home Medical. I'm pleased to have Hardik Mehta, our Chief Financial Officer; and Tom
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
